CDC Recommends Novavax COVID-19 Vaccine for Adolescents

The Centers for Disease Control and Prevention (CDC) has recommended the use of Novavax’s COVID-19 vaccine for children ages 12-17 for primary series vaccination. See the CDC statement. This recommendation is in line with the FDA’s Emergency Use Authorization of the vaccine for this age group. A limited supply of Novavax is available for Health Center COVID-19 Vaccine Program participants. Health centers can make a one-time order of one package (100 doses) per health center site. See these CDC resources for more information: